Autism


FOR IMMEDIATE RELEASE

Contact: Sharon Phillips

Phone: 1-954-575-4973

Cell: 1-954-540-1896

Twitter: HBOT 2010

Email: Sharon@hbot2010.net

or visit: www.hbot2010.net

INTERNATIONAL MEDICAL SYMPOSIUM “HBOT 2010” SET FOR IRVINE MARRIOTT, JULY 22-25

Monday, June 7th, Newport Beach, CA: Physicians and medical practitioners from around the globe will gather at the Irvine Marriott Hotel July 22-25, for “HBOT 2010”, an educational symposium, of world-wide medical significance.

Their focus will be on the healing and life sustaining benefits of oxygen, in the treatment of serious medical conditions. New to this year’s symposium will be the latest information on the treatment of war veterans with blast injuries, as well as cutting edge information on HBOT’s use for people with cancer and diabetes.

Hyperbaric Oxygenation Therapy Treatment, (known as HBOT), originated with the treatment of deep sea divers many years ago. Today it is successfully used to treat a wide range of illnesses, injuries and chronic conditions. “Dozens of scientific papers will be presented by international specialists, who are making medical history using oxygen — in its many forms — for healing and sustaining life. This conference will feature the most focused group of oxygen specialists in the world,” said Dr. Donald L. Jolly-Gabriel, Ph.D., Chairman of the Richard A. Neubauer Research Institute, (RANRI) sponsors of the event. This is the 7th bi-annual symposium, presented by the institute.

Some 30 experts, using oxygen in the successful treatment of such diverse conditions as: traumatic brain injury, autism, cerebral palsy, lyme disease, spinal cord injury, alzheimer’s, stroke, diabetic wounds, multiple sclerosis, near-drowning, coma, anoxic encephalopathy, childhood mitochondrial diseases and more; will meet in Orange County, CA., for the first time. An exposition featuring some of the most advanced HBOT equipment and items in related fields will also be available to those in attendance.

“This forum provides a rare opportunity for the public to join the medical community in learning about break-through modalities in use here and abroad, to treat these serious conditions,” Jolly-Gabriel said. “Parents who are seeking alternative treatments for children with any of these conditions are urged to attend. They will interact doctors using HBOT and learn first-hand from and patients how HBOT has changed their prognosis and enhanced their lives.

“Oxygen is God’s gift to us,” Jolly-Gabriel added. “It is the single most important element necessary to sustain life. Although it is readily available everywhere, we are only now beginning to realize its true medical significance. It is a magnificent step forward in medicine.” The symposium will provide educational interaction with many of the world’s most eminent experts in the field.

OUTSTANDING SPEAKERS

Among featured speakers will be professor K. K. Jain, author of, “The Handbook of Hyperbaric Oxygen Therapy,” (now the “Textbook of Hyperbaric Medicine, currently in its fifth edition).” Jain is a retired professor and a highly respected consultant in neurology and hyperbaric medicine. He is also the author of more than 415 publications including 16 books on related topics.

Karen Simmons, CEO and founder of “Autism Today,” will be featured at an Author’s Luncheon Friday, July 23 at noon. Simmons, is the co-author of “Chicken Soup for the Soul, Children with Special Needs,” (co-authored with Jack Canfield, Mark Victor Hansen and Heather McNamara); and both “The Official Autism 101 Manual,” (an IPPY Gold Medal winner); and the recently released, “Autism Tomorrow, The Complete Guide to helping your Child Thrive in the Real World.”

Dr. Paul Harch, of the University of Louisiana Medical Center, who developed the HBOT protocol being used to restore the lives of American military personnel, following Traumatic Brain Injuries in combat, will be lauded for his work, during the symposium.

In addition, Some of the most recent studies conducted by world renowned brain specialist Dr. Daniel Amen, M.D., of Newport Beach, will also be presented.

 

WHO SHOULD ATTEND

HBOT 2010 is designed not only for medical professionals, but for or those who are affected by any of the conditions listed above, or involved in related associations, (i.e. the America Cancer Society, The Autism Society, the Multiple Sclerosis Society, etc.). The HBOT 2010 agenda includes new approaches in oxygen therapy for the treatment and management of these illnesses.

Attendance will be beneficial to medical professionals including: Neurologists, Pediatricians, Neonatologists, Perinatologists, Physical Therapists, Physiatrists, Orthopedic Surgeons and other professionals. It will afford them new insights into this remarkable medical option as well as practical applications for its use in conjunction with their specialties. Non-professionals such as: care-takers in coma recovery cases, stroke recovery or family members assisting people with disabilities, will also find this program beneficial. “We have done everything possible to make attending this conference exciting, convenient and affordable,” Jolly-Gabriel said. HBOT 2010 has negotiated a conference rate at the Irvine Marriott Hotel, of just $109 per night for those who register before June 15.

Register on-line at http://www.hbot2010.net/index.php. Or, visit the web site for additional information on the coming symposium, conference and exposition.

 (Medical writers and bloggers, affiliated recognized media outlets, are invited to cover the event)

Sharon Phillips

HBOT2010 – July 22-25 Marriott Hotel, Irvine, California

Tel: 954 540 1896

Fax: 954 827 0723

sharon@hbot2010.net

www.hbot2010.net

http://twitter.com/HBOT2010

Advertisements

I recently received the following paper from Professor Philip James.

“Oxygen Treatment for Children with Autism

Philip B James Emeritus Professor of Medicine, University of Dundee

Until the 1990s few children were labelled as ‘autistic’ and it is clear that the recent epidemic is not because of better diagnosis, it is because some aspect of the medical management of children at birth or in early childhood has changed.

The blood vessels of the brain are different to those in the rest of the body; they form a barrier because many substances present in blood are toxic. The barrier, known as the blood-brain barrier or ‘BBB’ needs energy to work properly and so is affected by lack of oxygen. Brain damage due to failure of the BBB can occur at any time during life but especially, as MRI has shown, at birth. After an initial insult the barrier may remain damaged as it is, for example, in multiple sclerosis patients.

Medical practice lags well behind the latest research findings about oxygen from biological scientists and oxygen is simply regarded as necessary for the production of energy. However, it has been shown that oxygen levels control genes including those responsible for new blood vessel formation, the control of inflammation and the release of stem cells into the circulation. These processes apply to the repair of all tissues but especially the brain.

Breathing is necessary to gain oxygen for normal function but also for recovery from injury or illness. Unfortunately, injury and disease involve blood vessels and this often restricts the delivery of oxygen just when it is most needed for repair Misunderstandings about the toxicity of oxygen have generally clouded judgement about the use of high levels in treatment. Enormous experience exists in aviation, space and underwater medicine about the safety of using oxygen in treatment.

To significantly increase the level of oxygen carried in the blood needs a pressure chamber and it is well-established, if not well-known, that giving a high level of oxygen for just one hour a day may promote the repair of tissues when all other medical interventions have failed. In other words giving more oxygen extends the envelope of natural recovery.

There is no substitute for oxygen and if giving more does not help a patient it is not because oxygen does not ‘work’ it is because the damage has gone too far to allow normal recovery. However, the key question is how many treatment sessions are needed and this is a difficult problem because the treatment is time consuming.

The original studies of oxygen treatment for multiple sclerosis sufferers used a course of 20 sessions and this number was also used for the controlled studies. Over the last 27 years the UK charity centres have also used an initial course of 20 sessions followed by weekly maintenance sessions because MS is a progressive illness. A course of 20 sessions on a daily basis for five days a week means that a course can be completed in a month. If assessment shows continued improvement the course can be repeated after a suitable interval and most centres report using a gap of four weeks. The evidence supports using oxygen by hood at 1.5 ata or 1.75 ata using a mask. However benefit has been reported at pressures as low as 1.3 ata with 24% oxygen. March 2009”